Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Slaton

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The Journal of Urology|December 24, 1997
Transitional cell carcinoma of the bladder with involvement of vasa deferentiaA M Kaufman, J W Slaton, B A Czerniak, et al.
The Journal of Urology|March 21, 1998
Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinomaD A Levy, J W Slaton, D A Swanson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and scheduleJ W Slaton, P Perrotte, K Inoue, et al.
Cancer|December 11, 1999
Rationale for bladder-sparing surgery in patients with locally advanced colorectal carcinomaM D Balbay, J W Slaton, N Trane, et al.
The Journal of Urology|March 21, 1998
Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinomaD A Levy, D A Swanson, J W Slaton, et al.
Oncology Reports|August 10, 2001
Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8K Inoue, C G Wood, J W Slaton, et al.
Journal of Surgical Oncology|April 1, 1995
Use of ileal urinary diversion in conjunction with intraoperative radiotherapyJ W Slaton, K A Kropp, H W Merrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factorK Inoue, P Perrotte, C G Wood, et al.
Urology|June 28, 2000
Biosafety of in vivo adenovirus-p53 intravesical administration in miceP Perrotte, M Wood, J W Slaton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomyK Inoue, J W Slaton, T Karashima, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Journal of Urology|December 24, 1997
Transitional cell carcinoma of the bladder with involvement of vasa deferentiaA M Kaufman, J W Slaton, B A Czerniak, et al.
The Journal of Urology|March 21, 1998
Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinomaD A Levy, J W Slaton, D A Swanson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and scheduleJ W Slaton, P Perrotte, K Inoue, et al.
Cancer|December 11, 1999
Rationale for bladder-sparing surgery in patients with locally advanced colorectal carcinomaM D Balbay, J W Slaton, N Trane, et al.
The Journal of Urology|March 21, 1998
Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinomaD A Levy, D A Swanson, J W Slaton, et al.
Oncology Reports|August 10, 2001
Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukin-8K Inoue, C G Wood, J W Slaton, et al.
Journal of Surgical Oncology|April 1, 1995
Use of ileal urinary diversion in conjunction with intraoperative radiotherapyJ W Slaton, K A Kropp, H W Merrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factorK Inoue, P Perrotte, C G Wood, et al.
Urology|June 28, 2000
Biosafety of in vivo adenovirus-p53 intravesical administration in miceP Perrotte, M Wood, J W Slaton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomyK Inoue, J W Slaton, T Karashima, et al.
Pageof 3